Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong · Delayed Price · Currency is HKD 2.305
-0.030 (-1.28%)
Sep 18, 2026, 4:08 PM HKT
Hua Medicine (Shanghai) Market Cap
Hua Medicine (Shanghai) has a market cap or net worth of 2.3 billion as of September 18, 2026. Its market cap has decreased by -44.17% in one year.
Market Cap
2.30B
Enterprise Value
1.47B
Revenue
755.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.31
ChartMarket Cap Chart
Since September 14, 2018, Hua Medicine (Shanghai)'s market cap has decreased from 8.71B to 2.30B, a decrease of -73.63%. That is a compound annual growth rate of -15.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.30B | -24.52% |
| Dec 31, 2025 | 3.04B | 112.44% |
| Dec 31, 2024 | 1.43B | -25.71% |
| Dec 29, 2023 | 1.93B | -46.67% |
| Dec 30, 2022 | 3.62B | -0.33% |
| Dec 31, 2021 | 3.63B | -34.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Tong Ren Tang Chinese Medicine Company | 4.73B |
| CF PharmTech | 4.47B |
| Edding Genor Group Holdings | 3.30B |
| CPBIO Holding Company | 2.12B |
| VISEN Pharmaceuticals | 2.08B |
| Jacobson Pharma Corporation | 1.93B |
| Dawnrays Pharmaceutical (Holdings) | 1.48B |
| Golden Throat Holdings Group Company | 1.43B |